Introduction {#sec1-1}
============

Chronic diseases are conditions, which are usually irreversible, persist for a long duration, and require individuals to seek care over a life-time. These conditions include hypertension, diabetes, heart diseases, stroke, chronic respiratory conditions, cancers, autoimmune, degenerative, and endocrine diseases. Chronic diseases are now leading cause of mortality in the world, representing 63% of all deaths. Out of the 36 million people who died from chronic disease in 2008, 9 million were under 60 and 90% of these premature deaths occurred in low- and middle-income countries.\[[@ref1]\]

Increasing awareness, improved health-seeking behaviors, and better use of screening strategies have led to identification of multiple chronic conditions (MCCs) in the same individual.\[[@ref2]\] MCC is defined as the presence of two or more disease conditions in the same individual.\[[@ref3]\] Existence of MCCs poses various challenges for individuals as well as health systems, such as higher expenditure,\[[@ref4]\] greater clinical and therapeutic complexity,\[[@ref5]\] poor adherence to therapies,\[[@ref6]\] need for greater emotional support,\[[@ref7]\] and potential need for comprehensive care programs, which optimize number of care-providers.\[[@ref8]\] Estimates about the prevalence of MCC in the population are available from some countries such as United States (26%),\[[@ref9]\] Spain (24%),\[[@ref10]\] Taiwan (17%),\[[@ref11]\] and Singapore (16%).\[[@ref12]\] Prevalence is higher in those who seek more health-care, such as Medicare beneficiaries in United States, where prevalence is as high as 68%.\[[@ref13]\] Increasing prevalence of MCC presents with various health system challenges. Health systems traditionally focus on research and treatment of single conditions, and need to be strengthened to take care of complexities of multiple comorbidities.\[[@ref14]\]

There is paucity of studies that have evaluated either pattern or prevalence of MCCs in a low-and-middle-income country setting. Since various studies have shown increasing prevalence of single chronic diseases (such as diabetes or hypertension)\[[@ref15][@ref16]\] in India, there is a need to understand prevalence or patterns of MCCs as well. The current study is designed to understand proportion and pattern of MCC among adults seeking out-patient care in an urban setting in India.

Materials and Methods {#sec1-2}
=====================

Design {#sec2-1}
------

Authors performed a hospital-based cross-sectional study to determine prevalence and patterns of MCCs. Institutional Ethics Committee of All India Institute of Medical Sciences, Bhopal, approved the design and conduct of the study. All participants provided a written informed consent.

Setting {#sec2-2}
-------

All India Institute of Medical Sciences, Bhopal, a public sector teaching hospital in central India, currently provides ambulatory care services largely to urban population. The current study was performed in medicine, neurology and orthopedics outpatient departments of the institute. All outpatients are electronically registered at the hospital and receive a unique numerical identifier, which is used for all subsequent visits.

Participants {#sec2-3}
------------

Out-patient case records of all consecutive patients who visited medicine, neurology and orthopedics out-patient departments during a 1 month period (15^th^ May to 15^th^ June 2013) were included. We excluded children and adolescents (age \<18 years). No other exclusions were applied. Since duplicate visits by the same patient in either in the same department or across departments were likely, we used unique numerical identifier to filter such records.

Procedures {#sec2-4}
----------

Authors identified 18 chronic diseases across five axes: Chronic vascular disease, immunological dysfunction, degenerative articular disease, chronic neurological dysfunction, and miscellaneous. These axes are based on pathophysiological mechanism for included conditions. Included conditions were defined based on standard criteria \[[Box 1](#T1){ref-type="table"}\]. Patients were approached for participation at the end of their clinical visit, and consent obtained to record information about demographic (age, gender, years of education), clinical (chronic disease diagnosis, years since diagnosis), and average monthly out-of-pocket medical expenditure by direct interview or from case records.

###### 

Chronic disease axis, disease conditions included and basis of diagnosis for the study

![](JFMPC-4-411-g001)

We included those conditions, which were already known for that individual, at the end of the out-patient visit, and were documented by the treating physicians. No additional screening strategies were used for conditions that may have been unknown at the time of out-patient visit.

Statistical analysis and sample size {#sec2-5}
------------------------------------

We enumerated number of chronic disease conditions in all participants, and estimated proportion of individuals with single and MCCs. We estimated means and standard deviation, and proportions as measures of central tendency and dispersion for relevant variables. We estimated 95% CI of proportions as a measure of precision. We used Chi-square and ANOVA tests of trend to determine if proportions with MCCs or out-of-pocket expenditure significantly vary with number of chronic disease diagnoses. All statistical analyses were done using either Microsoft Excel or STATA version 12.0.

Results {#sec1-3}
=======

A total of 946 new patient-visits were logged in out-patient departments of medicine, orthopedics and neurology during 1 month study period. After excluding the duplicate visits (either in the same department or across departments), and those with in-complete records, a total of 785 unique patients were included in the analysis. Of these, 235, 299 and 251 of them had primarily visited neurology, orthopedics and medicine out-patient departments, respectively. Overall, the participants were middle aged (average age 45.01 (SD 16.01)), and half of them were women (396/785, 50.4%). A total of 286 (36%) participants had at least one chronic disease diagnosis, and 183 (23%) had MCCs. There were a total of 643 disease diagnoses, chronic vascular disease axis being the most common, followed by immunological and degenerative disease axis. About four fifths of individuals with hypertension or diabetes who visited out-patient department had a co-existing disease. About two thirds of all individuals with thyroid dysfunction, and half of all individuals with rheumatoid arthritis had other comorbidity \[[Table 1](#T2){ref-type="table"}, [Figure 1](#F1){ref-type="fig"}\].

###### 

Spectrum of Chronic disease diagnosis amongst study population (*n*=785)
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![The billion-pound-o-gram depicting chronic disease spectrum. Area of each shape in this billion-pound-o-gram is proportional to the prevalence of disease condition in the current study](JFMPC-4-411-g003){#F1}

We evaluated patterns of overlap among various chronic disease axes. Overlap of multiple conditions from within axis 1 (chronic vascular disease axis) was most frequent, comprising 7% of all participants. Overlap between axis 1 and axis 2 (immune dysfunction axis) was next (5% of all cases), followed by overlap between axis 1 and axis 3 (articular degeneration) comprising 4% of all participants. Of 23% of participants who had MCCs, 21% had overlap due to one or more chronic vascular conditions \[[Table 2](#T3){ref-type="table"}\].

###### 

Overlap of Chronic diseases category axis (*n*=785)
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The proportion of participants with two, or three chronic diseases was 8.7% and 8.8% each. Only 0.5% of all participants had six or more chronic conditions. The monthly out-of-pocket expenditure was progressively higher for individuals with additional chronic condition, and this was statistically significant \[[Figure 2](#F2){ref-type="fig"}\].

![Prevalence and out-of-pocket expenditure for one or more chronic coexisting conditions. Proportion of multiple chronic conditions (blue line) and its 95% confidence interval (blue shaded area) shows a decreasing trend (Chi-square goodness of fit test (chi square 1609.6, df 6, *P* \< 0.0001). Increasing trend for out-of-pocket expenditure in rupees (red line) and its 95% confidence interval was statistically significant (ANOVA *P* \< 0.001)](JFMPC-4-411-g005){#F2}

Discussion {#sec1-4}
==========

The current study demonstrates that about two thirds of all individuals with a chronic disease who visit out-patient department have MCCs. Most overlap is due to one or more chronic vascular disease. Individuals with more chronic conditions have significantly more average out-of-pocket expenditure for medical supplies. This study, to our knowledge, is a first documented estimate of MCCs from India. We sampled consecutive patients from three out-patient departments to collect information about chronic disease diagnoses based on standard diagnostic criteria.

Compared to high-income countries such as United States, the prevalence of MCCs in our hospital-based study is low (68% vs 23%). This is likely due to a true lower prevalence or disease unawareness in our population. As developing nations try to bridge "unscreened-gap" in chronic diseases, we are likely to observe a greater prevalence of MCCs. This will have huge implications for low- and middle-income countries, as MCCs make clinical care algorithms more complex.\[[@ref14]\] There is a need to develop mechanisms so that fragile health systems can also deal with this complexity. First step in this direction is to understand prevalence and patterns of MCCs.

In MCCs spectrum, most overlap is contributed by chronic vascular disease axis,\[[@ref9][@ref11]\] and results of our study are similar in this regard. Vascular diseases such as diabetes and hypertension are considered as entry points of cardiovascular disease control,\[[@ref17]\] and these may as well be entry points for entire chronic disease spectrum. Prevalent patterns of MCCs suggest that multiple vascular conditions occurring together are common. Thus, there is a need to move from disease specific to a disease axis guideline, which encompasses conditions such as hypertension, diabetes, dyslipidemia, obesity, and even secondary prevention of secondary complications under a single umbrella. Similarly we need to take into account chronic vascular conditions when we are managing immunological conditions (such as thyroid dysfunction or SLE), or degenerative conditions (such as osteoarthritis or osteoporosis). These paradigms are required, as current chronic disease guidelines focus on individual conditions, and mostly do-not take into account multiple co-morbidities.\[[@ref18]\] We need to take patterns of MCCs into account, as there are potential interactions between disease conditions, prescribed medications,\[[@ref14]\] and potential fragmentation of care due to multiplicity of providers.\[[@ref19]\]

Our study has certain limitations. First, this is a hospital-based study and this selection bias is likely to overestimate the prevalence more than that truly existing in the populations. Secondly, we did not perform any biochemical tests to screen individuals for additional chronic disease diagnoses. Thus, our prevalence reflects only those conditions which patients and physicians were aware of. This information bias is likely to result in underestimation of the true prevalence. Thirdly, we limited diagnostic possibilities to most common multiple chronic disease diagnoses. We did not include cancers, mental health conditions, and skin conditions that may also require long-term therapies. A wider chronic disease spectrum is likely to result in higher prevalence of MCCs. Despite these limitations, these results indicate that a significant proportion of individuals with a chronic disease diagnosis are likely to have MCCs.

Conclusion {#sec1-5}
==========

MCCs are an emerging problem in low-and-middle income countries as shown in our study. There is a need to incorporate MCCs in medical teaching, research needs, as well as in service delivery. There are many unmet research needs, especially about defining outcomes that we need to achieve while managing MCCs.\[[@ref20][@ref21]\] For effective service delivery, we need to move from disease specific to group specific management of disease conditions. We also need to empower primary care providers so that appropriate screenings and therapies are introduced in a timely manner among those with MCCs. In this context, it is imperative to introduce mechanisms that ensure continuity of care, since co-existence of multiple chronic diseases is common in those who seek hospital-based care. This fact has important implications for education and clinical decision making in Primary care.
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